The Parasympathetic Nervous System: Function and Anatomy Study Guide
This guide provides a comprehensive overview of the parasympathetic nervous system (PSNS), a crucial component of the autonomic nervous system responsible for involuntary bodily functions. It delves into the PSNS's primary role in energy conservation, often characterized by the "rest and digest" state, and contrasts it with the "fight or flight" response. The guide explains the anatomical structure of the PSNS, including its two-neuron relay system involving preganglionic and postganglionic neur
Save this study guide to your study set
Your learning path
Introduction to Acetylcholine and Cholinergic Neurons
Neuroscience of Acetylcholine
Acetylcholine is a neurotransmitter synthesized from choline and acetyl coenzyme A that acts on nicotinic and muscarinic receptors to influence muscle contraction, memory, arousal, and attention.
- acetylcholine
- cholinergic neurons
- nicotinic acetylcholine receptors
- acetylcholinesterase
- neuromuscular junctions
- autonomic nervous system
- basal forebrain
- brainstem
- Import & open
Flashcards
Import to get started
- Import & open
Quiz
Import to get started
- Import & open
Practice test
Import to get started
- Import & open
Listen
Import to get started
- Import & open
Tutor Me
Import to get started
- Import & open
Watch
Import to get started
- Import & open
Chat
Import to get started
- Import & open
Arcade
Import to get started
Overview of the Parasympathetic Nervous System
The Parasympathetic Nervous System Overview
The parasympathetic nervous system is a subdivision of the autonomic nervous system that controls automatic processes like digestion, heart rate, and respiration.
- autonomic nervous system
- parasympathetic nervous system
- energy conservation
- preganglionic neurons
- postganglionic neurons
- ganglia
- acetylcholine
- brainstem
- sacral spinal cord
- vagus nerve
- Import & open
Flashcards
Import to get started
- Import & open
Quiz
Import to get started
- Import & open
Practice test
Import to get started
- Import & open
Listen
Import to get started
- Import & open
Tutor Me
Import to get started
- Import & open
Watch
Import to get started
- Import & open
Chat
Import to get started
- Import & open
Arcade
Import to get started
Anticholinergic and Cholinergic Toxidromes
Cholinergic and Anticholinergic Toxidromes
This video examines anticholinergic and cholinergic toxidrome signs, symptoms, and causes.
- Anticholinergic toxidrome
- Anticholinergic signs and symptoms
- Anticholinergic causes
- Cholinergic signs and symptoms
- Cholinergic causes
- SLUDGE mnemonic
- Triple screen
- Organophosphate insecticides
- Antihistamines
- Tricyclic anti-depressants
Neuroscience of MDMA Mechanisms
Neuroscience of MDMA Mechanisms
MDMA is a stimulant drug that inhibits transporter proteins to increase neurotransmitter activity in the synaptic cleft.
- MDMA
- stimulant drug
- amphetamine
- prosocial effects
- transporter proteins
- serotonin
- dopamine
- norepinephrine
- synaptic cleft
- serotonin receptor
- oxytocin
Neuroscience of Caffeine and Adenosine Receptors
Neuroscience of Caffeine and Adenosine
Caffeine is a stimulant drug and methylxanthine that acts as an antagonist at adenosine receptors to promote wakefulness and arousal.
- caffeine
- methylxanthines
- adenosine receptors
- antagonist
- neurotransmitters
- dopamine
- norepinephrine
- wakefulness
Neuroscience of Nicotine and Acetylcholine Receptors
Neuroscience of Nicotine and Acetylcholine Receptors
Nicotine acts as an agonist at nicotinic acetylcholine receptors to cause neurotransmitter release and various behavioral effects.
- nicotinic acetylcholine receptors
- agonist
- neurotransmitter release
- depolarization
- dopamine
- nucleus accumbens
- acetylcholine
- norepinephrine
- sympathetic nervous system
- catecholamines
- epinephrine
- receptor desensitization
- tolerance
- upregulation
Alcoholic Effects on the Central Nervous System
Neuroscience of Alcohol Actions
Alcohol acts in the central nervous system by affecting GABA and glutamate receptors, dopamine transmission, and synaptic plasticity.
- GABAa receptors
- Positive allosteric modulator
- Glutamate inhibition
- Neural firing inhibition
- Serotonin receptors
- Glycine receptor function
- Adenosine reuptake inhibition
- Calcium channels
- Potassium channels
- Nicotinic acetylcholine modulation
- Mesolimbic dopamine pathway
- Long-term potentiation
- Synaptic plasticity
- Hippocampus memory disruption
Introduction to THC and Mechanism of Action
Neuroscience of THC and Cannabinoid Receptors
THC is the primary psychoactive component of cannabis that acts as a partial agonist at CB1 and CB2 G-protein coupled receptors to modulate neurotransmitter releases.
- $\Delta^9$-tetrahydrocannabinol (THC)
- Cannabinoids
- Tetrahydrocannabinolic acid (THCA)
- CB1 receptors
- CB2 receptors
- G-protein coupled receptors
- Partial agonist
- Neurotransmitter modulation
- Analgesia
- Cognitive function
- Sedation
- Euphoria
Understanding the Resting Membrane Potential
Understanding Neuronal Membrane Potential
The membrane potential of a neuron is maintained by the grouping of ions across the plasma membrane and the sodium-potassium pump.
- plasma membrane
- sodium ions
- chloride ions
- potassium ions
- organic anions
- resting membrane potential
- sodium-potassium pump
- ion channels
- equilibrium
Understanding the Action Potential
Understanding the Neuronal Action Potential
The action potential is a momentary reversal of membrane potential that serves as the basis for electrical signaling within neurons.
- action potential
- membrane potential
- resting membrane potential
- depolarization
- threshold membrane potential
- sodium channels
- sodium ions
- rising phase
- potassium channels
- potassium ions
- repolarization
- falling phase
- hyperpolarized
- refractory period
- axon terminals
- neurotransmitters
Understanding Sleep Stages and EEG Activity
Neuroscience of Sleep Stages
Sleep stages are defined based on the measurement of electrical activity in the brain using an electroencephalogram.
- electroencephalogram
- EEG
- sleep stages
- stage 1 sleep
- stage 2 sleep
- sleep spindles
- K complexes
- stage 3 sleep
- slow-wave sleep
- deep sleep
- delta waves
Stages of Sleep and REM Cycles
The sleep stages include stage 1, stage 2, stage 3, and rapid eye movement (REM) sleep characterized by EEG activity and vivid dreams.
- Stage 1 sleep
- Stage 2 sleep
- Stage 3 sleep
- Rapid eye movement (REM) sleep
- EEG activity
- Sleep cycles
- Vivid dreams
Understanding Malignant Hyperthermia Susceptibility
Malignant Hyperthermia Causes and Treatment
Malignant hyperthermia is a severe reaction to certain drugs used as anesthesia for surgery and other invasive procedures.
- malignant hyperthermia susceptibility
- volatile anesthetics
- depolarizing muscle relaxant
- gene mutations
- RYR1 gene
- autosomal dominant inheritance
- muscle rigidity
- rhabdomyolysis
- acidosis
Seizures and Pharmacological Management of Antiepileptics
Seizures and Epilepsy Manifestations
- Seizure
- Epilepsy
- Convulsions
- Tonic-clonic movements
- Etiologic factors
- Metabolic disorders
- Congenital malformations
- Genetic predisposition
- Perinatal injury
- Postnatal trauma
- Myoclonic syndromes
- Focal seizures
- Generalized seizures
- Electroencephalogram (EEG)
- Prodroma
- Aura
- Clonic phase
- Postictal phase
Status Epilepticus and Antiepileptic Drug Therapy
Management of status epilepticus and the use of antiepileptic drugs to control or prevent seizures through various mechanisms of action and pharmacological effects.
- Status epilepticus
- Pathophysiology of prolonged seizure activity
- Antiepileptic drugs (AEDs)
- Therapeutic drug monitoring
- Mechanism of action of anticonvulsants
- Adverse effects of phenytoin
- Seizure types including partial and generalized
- Gabapentin and GABA synthesis
- Nursing priorities for seizure management
- Patient education for long-term AED therapy
Understanding Guillain-Barré Syndrome
Clinical Features of Guillain Barre Syndrome
This content explains the progressive symmetrical weakness, flaccid paralysis, and paresthesia associated with Guillain Barre Syndrome.
- Guillain Barre Syndrome
- AIDP
- progressive symmetrical weakness
- ascending weakness
- flaccid paralysis
- paresthesia
- respiratory involvement
- facial muscle involvement
Guillain Barre Syndrome Subtypes and Manifestations
Guillain Barre Syndrome involves various subtypes including Miller Fisher Syndrome, acute motor and sensory axonal neuropathy, and pure sensory types characterized by autonomic nervous system involvement, respiratory muscle distress, and neurological manifestations.
- Guillain Barre Syndrome
- Acute motor and sensory axonal neuropathy
- dysphagia
- diplopia
- dysautonomia
- ophthalmoplegia
- areflexia
- ataxia
- respiratory muscle involvement
- autonomic nervous system features
- pure sensory subtype
- Pure motor type
Cholinergic and Cholinergic-Blocking Drugs
Cholinergic Drugs and Parasympathetic Stimulation
This content covers cholinergic drugs that stimulate the parasympathetic nervous system through direct-acting agonists and indirect-acting cholinesterase inhibitors.
- Parasympathetic nervous system
- Indirect-acting cholinergic agonists
- Cholinesterase inhibitors
- Acetylcholinesterase
- Nicotinic receptors
- Reversible and irreversible cholinesterase inhibitors
- Donepezil
- Pyridostigmine
- Succinylcholine
- Physostigmine
- Parkinson's disease
- Glaucoma
- Neuromuscular blockade
Pharmacological Management of Neurological Disorders
This content discusses cholinergic drugs, cholinergic crisis, myasthenia gravis, Alzheimer's disease, Huntington's disease, and Parkinson's disease.
- Cholinergic crisis
- SLUDGE syndrome
- Parasympathetic nervous system
- Acetylcholine
- Atropine
- Huntington's disease
- Basal ganglia degeneration
- Gamma-aminobutyric acid (GABA)
- Parkinson's disease
- Dopaminergic nigrostriatal pathway
- Bradykinesia
- Hyperkinesia
- Paroxysmal dyskinesias
Cholinergic-Blocking Drugs and Mechanisms
Cholinergic-blocking drugs, also known as anticholinergics, act as competitive antagonists that inhibit the actions of acetylcholine in the parasympathetic nervous system.
- Cholinergic-blocking drugs
- Competitive antagonists
- Parasympathetic nervous system
- Scopolamine hydrobromide
- Dicyclomine
- Oxybutynin
- Tolterodine
- Benztropine
- Cycloplegia
- Urinary retention
- Decreased gastrointestinal motility
- Decreased bronchial secretions
- Physostigmine
Pharmacology of Parkinson's and Motor Neuron Disorders
Pharmacology and Pathophysiology of Neurological Disorders
This content discusses antiparkinsonian drug therapies, dopamine neurotransmitter imbalances, and various neurodegenerative, demyelinating, and neuromuscular junction disorders.
- Parkinson's disease
- Dopamine replacement therapy
- Nondopamine dopamine receptor agonists
- Indirect-acting dopaminergic drugs
- MAO-B inhibitors
- Dopamine modulators
- COMT inhibitors
- Anticholinergic therapy
- Amyotrophic lateral sclerosis
- Multiple sclerosis
- Guillain-Barré syndrome
- Neurotransmitter imbalance
- Demyelinating disorders
- Neuromuscular junction disorders
Neurological Conditions: Delirium and Dementia
Neurological Pathophysiology of Delirium
This content explores the acute brain dysfunction of delirium, comparing its clinical manifestations and neurotransmitter imbalances to dementia.
- delirium
- dementia
- acute brain dysfunction
- impaired attention
- impaired awareness
- impaired cognition
- hypoxia
- inflammation
- neurotransmitter imbalances
- acetylcholine deficiency
- dopamine excess
- hyperactive delirium
- hypoactive delirium
- mixed delirium
- clinical manifestations
Neuroscience of Opioid Tolerance and Withdrawal
Neuroscience of Opioid Tolerance and Withdrawal
Exposure to opioid drugs leads to tolerance involving a decreased response to the drug and adaptive changes like a reduction in the number of functional receptors.
- opioid tolerance
- decreased response
- adaptive changes
- reduction in functional receptors
- dysregulation
- withdrawal effects
Benefits of Methadone Treatment
Methadone Treatment and Opioid Overdose Risks
Methadone treatment is associated with controlled doses, a lower risk of fatal and nonfatal overdose, and a reduction in intravenous drug use.
- methadone treatment
- opioid overdose risk
- intravenous drug use
- blood-borne disease risk
Anaesthetics, Neuromuscular Blockers, and Muscle Relaxants
Pharmacology of General and Local Anaesthesia
Anaesthesia drugs reduce or eliminate pain by depressing nerve function in the central nervous system and peripheral nervous system through general or local administration.
- Local anaesthesia
- Inhalational anaesthetics
- Parenteral anaesthetics
- Adjunct anaesthetics
- Balanced anaesthesia
- Anticholinergics
- Opioids
- Antihistamines
- Benzodiazepines
- Sedative-hypnotics
- Overton-Meyer theory
- Malignant hyperthermia
- Dexmedetomidine
- Ketamine hydrochloride
- Nitrous oxide
- Propofol
- Sevoflurane
- Procedural sedation
- Nerve block anaesthesia
Neuromuscular Blocking Drugs and Anaesthesia
Neuromuscular blocking drugs prevent nerve transmission in skeletal and smooth muscle, resulting in muscle paralysis used with anaesthetics during surgery.
- Neuromuscular blocking drugs
- Nondepolarizing drugs
- Depolarizing drugs
- Succinylcholine
- Vecuronium
- Muscle paralysis
- Endotracheal intubation
- Anticholinesterase drugs
- Mechanical ventilation
- Malignant hyperthermia
- Preoperative assessment
- Postoperative monitoring
Muscle Relaxants Indications and Mechanisms
Muscle relaxants are used for the relief of painful musculoskeletal conditions, spasticity, and choreiform movement through CNS depression or direct action on muscle fibres.
- Muscle relaxant indications
- Baclofen
- Cyclobenzaprine hydrochloride
- Dantrolene sodium
- Tizanidine hydrochloride
- Mechanism of action
- CNS depression
- Excitation-contraction coupling
- Sarcoplasmic reticulum
- GABA derivatives
- Adverse effects
- Contraindications
- Drug interactions
- Nursing assessments
- Nursing interventions
Multiple Sclerosis Types, Causes, and Diagnosis
Understanding Multiple Sclerosis Treatment and Management
Management of Multiple Sclerosis involves using intravenous corticosteroids to relieve symptoms during acute attacks and disease modifying drugs to reduce the rate of further attacks and disability.
- intravenous corticosteroids
- disease modifying drugs
- interferon beta preparations
- T and B cells modulation
- monoclonal antibody
- acrylizumab
- mitosanthrone
- siponimod
- cladrabine
- pharmacotherapy
- neural Rehabilitation
- occupational therapy
Cholinergic and Anticholinergic Medications and Neurodegenerative Disorders
Neurological Pathophysiology and Medication Applications
- Parkinson's disease
- Cholinergic drugs
- Glaucoma
- Skeletal muscle impairment
- Airway constriction
- Heart rate decrease
- Vasodilation
- Sphincter relaxation
- Contraindications
Neurological Pathophysiology and Treatment Challenges
- Parkinson's disease
- Huntington's disease
- Amyotrophic lateral sclerosis (ALS)
- Multiple sclerosis (MS)
- Guillain-Barré syndrome
- Cholinergic crisis
- Anticholinergic toxicity
- Dopamine deficiency
- Acetylcholine
- Parasympathetic nervous system stimulation
- Demyelination
- Neurotransmitter imbalance
- Muscle rigidity
- Tremors
- Postural instability
Make it your own.
Keep these readings and topics in a new study set, or add them to one you already use.